Orthofix Medical Inc. (OFIX)
NASDAQ: OFIX · Real-Time Price · USD
12.46
-0.16 (-1.27%)
Mar 9, 2026, 4:00 PM EDT - Market closed

Orthofix Medical Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-92.19-126-151.4-19.75-38.38
Depreciation & Amortization
77.3260.0653.0629.0229.6
Stock-Based Compensation
28.6932.4635.7118.4415.43
Other Adjustments
41.0378.5270.844.8947.35
Change in Receivables
-1.58-9.53-10.41-6.74-7.05
Changes in Inventories
-10.75-5.55-58.05-33.04-10.21
Changes in Accounts Payable
2.6-5.578.642.284.25
Changes in Accrued Expenses
-2.279.534.070.631.01
Changes in Unearned Revenue
----4.79-9.06
Changes in Other Operating Activities
-9.5-8.141.79-2.49-14.47
Operating Cash Flow
33.3525.79-45.75-11.5418.48
Operating Cash Flow Growth
29.30%----75.13%
Capital Expenditures
-34.63-34.88-62.05-23.16-17.79
Purchases of Intangible Assets
-----1.81
Purchases of Investments
-----2.17
Proceeds from Sale of Investments
-7.4-0.13-
Other Investing Activities
0.03-0.128.92-1.5-1.25
Investing Cash Flow
-34.6-27.58-33.13-24.53-23.01
Long-Term Debt Issued
-197.6174.5--
Long-Term Debt Repaid
--142.5-105.9--
Net Long-Term Debt Issued (Repaid)
-55.168.6--
Issuance of Common Stock
5.936.265.134.348.82
Repurchase of Common Stock
-0.43-5.31-4.4-1.73-2.56
Net Common Stock Issued (Repurchased)
5.50.950.732.616.27
Other Financing Activities
-6.28-5.34-4.01-2.69-9.89
Financing Cash Flow
-0.7950.7165.32-0.08-3.62
Effect of Exchange Rate Changes on Cash and Cash Equivalents
1.41-0.940.62-1-0.82
Net Cash Flow
-0.6247.98-12.94-37.15-8.97
Free Cash Flow
-1.28-9.09-107.8-34.70.69
Free Cash Flow Growth
-----98.83%
FCF Margin
-0.16%-1.14%-14.44%-7.53%0.15%
Free Cash Flow Per Share
-0.03-0.24-2.94-1.730.04
Levered Free Cash Flow
-69.41-55.44-135.33-51.3-55.04
Unlevered Free Cash Flow
-57.41-67.71-189.11-46.35-40.31
Updated Feb 24, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q